| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ceramide floppase activity | 2.07e-05 | 3 | 53 | 2 | GO:0099038 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 4.13e-05 | 4 | 53 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 1.92e-04 | 8 | 53 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.98e-04 | 49 | 53 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | muscle alpha-actinin binding | 7.10e-04 | 15 | 53 | 2 | GO:0051371 | |
| GeneOntologyMolecularFunction | floppase activity | 8.10e-04 | 16 | 53 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCG4 SLC38A9 SLC26A5 PKD2 PKD2L1 GRIA1 SLC45A2 SLC44A4 ABCB1 ABCB4 | 9.50e-04 | 1180 | 53 | 10 | GO:0022857 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.06e-03 | 293 | 53 | 5 | GO:0008514 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 1.27e-03 | 20 | 53 | 2 | GO:0046624 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 1.27e-03 | 20 | 53 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.60e-03 | 477 | 53 | 6 | GO:0022804 | |
| GeneOntologyMolecularFunction | transporter activity | ABCG4 SLC38A9 SLC26A5 PKD2 PKD2L1 GRIA1 SLC45A2 SLC44A4 ABCB1 ABCB4 | 1.85e-03 | 1289 | 53 | 10 | GO:0005215 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 2.21e-03 | 207 | 53 | 4 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 2.25e-03 | 208 | 53 | 4 | GO:0005342 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.50e-03 | 28 | 53 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 2.59e-03 | 103 | 53 | 3 | GO:0004553 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.04e-03 | 109 | 53 | 3 | GO:0042626 | |
| GeneOntologyMolecularFunction | alpha-actinin binding | 3.06e-03 | 31 | 53 | 2 | GO:0051393 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.06e-03 | 31 | 53 | 2 | GO:0099604 | |
| GeneOntologyBiologicalProcess | response to water | 5.39e-06 | 14 | 52 | 3 | GO:0009415 | |
| GeneOntologyBiologicalProcess | cellular response to hydrostatic pressure | 1.87e-05 | 3 | 52 | 2 | GO:0071464 | |
| GeneOntologyBiologicalProcess | ceramide translocation | 1.87e-05 | 3 | 52 | 2 | GO:0099040 | |
| GeneOntologyBiologicalProcess | sphingolipid translocation | 6.20e-05 | 5 | 52 | 2 | GO:0099039 | |
| GeneOntologyBiologicalProcess | cellular response to water stimulus | 9.29e-05 | 6 | 52 | 2 | GO:0071462 | |
| GeneOntologyBiologicalProcess | hemidesmosome assembly | 9.29e-05 | 6 | 52 | 2 | GO:0031581 | |
| GeneOntologyBiologicalProcess | response to hydrostatic pressure | 1.30e-04 | 7 | 52 | 2 | GO:0051599 | |
| GeneOntologyBiologicalProcess | response to acid chemical | 2.69e-04 | 228 | 52 | 5 | GO:0001101 | |
| GeneOntologyBiologicalProcess | peptide modification | 2.77e-04 | 10 | 52 | 2 | GO:0031179 | |
| GeneOntologyCellularComponent | membrane attack complex | 1.31e-04 | 7 | 53 | 2 | GO:0005579 | |
| GeneOntologyCellularComponent | apical plasma membrane | 2.18e-04 | 487 | 53 | 7 | GO:0016324 | |
| GeneOntologyCellularComponent | intercellular canaliculus | 2.24e-04 | 9 | 53 | 2 | GO:0046581 | |
| GeneOntologyCellularComponent | hemidesmosome | 3.42e-04 | 11 | 53 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | insulin-responsive compartment | 3.42e-04 | 11 | 53 | 2 | GO:0032593 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ABCG4 MGAM RAB4B SLC38A9 SEC23IP PKD2 GRIA1 SLC45A2 ASB14 PCSK4 RAB4A | 3.66e-04 | 1307 | 53 | 11 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | ABCG4 MGAM RAB4B SLC38A9 SEC23IP PKD2 GRIA1 SLC45A2 ASB14 PCSK4 RAB4A | 4.11e-04 | 1325 | 53 | 11 | GO:0012506 |
| GeneOntologyCellularComponent | apical part of cell | 7.02e-04 | 592 | 53 | 7 | GO:0045177 | |
| GeneOntologyCellularComponent | condensed nuclear chromosome | 1.60e-03 | 91 | 53 | 3 | GO:0000794 | |
| Domain | LANC_like | 2.28e-05 | 3 | 52 | 2 | PF05147 | |
| Domain | LanC-like_prot_euk | 2.28e-05 | 3 | 52 | 2 | IPR020464 | |
| Domain | LANC-like | 2.28e-05 | 3 | 52 | 2 | IPR007822 | |
| Domain | LANC_like | 2.28e-05 | 3 | 52 | 2 | SM01260 | |
| Domain | PKD_2 | 7.56e-05 | 5 | 52 | 2 | IPR003915 | |
| Domain | MACPF_CS | 1.13e-04 | 6 | 52 | 2 | IPR020863 | |
| Domain | Gal_Oxidase_b-propeller | 1.15e-04 | 34 | 52 | 3 | IPR015916 | |
| Domain | MACPF_2 | 1.58e-04 | 7 | 52 | 2 | PS51412 | |
| Domain | MACPF_1 | 1.58e-04 | 7 | 52 | 2 | PS00279 | |
| Domain | LAM_G_DOMAIN | 1.60e-04 | 38 | 52 | 3 | PS50025 | |
| Domain | LDLR_class-A_CS | 1.87e-04 | 40 | 52 | 3 | IPR023415 | |
| Domain | Laminin_G_2 | 1.87e-04 | 40 | 52 | 3 | PF02210 | |
| Domain | 6hp_glycosidase | 2.11e-04 | 8 | 52 | 2 | IPR012341 | |
| Domain | - | 2.11e-04 | 8 | 52 | 2 | 1.50.10.10 | |
| Domain | ABC_transporter_CS | 2.16e-04 | 42 | 52 | 3 | IPR017871 | |
| Domain | LamG | 2.49e-04 | 44 | 52 | 3 | SM00282 | |
| Domain | Ldl_recept_a | 2.66e-04 | 45 | 52 | 3 | PF00057 | |
| Domain | - | 2.84e-04 | 46 | 52 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 3.22e-04 | 48 | 52 | 3 | PS01209 | |
| Domain | ABC_tran | 3.22e-04 | 48 | 52 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.22e-04 | 48 | 52 | 3 | PS50893 | |
| Domain | MAC_perforin | 3.37e-04 | 10 | 52 | 2 | IPR001862 | |
| Domain | ABC_TRANSPORTER_1 | 3.43e-04 | 49 | 52 | 3 | PS00211 | |
| Domain | LDLRA_2 | 3.43e-04 | 49 | 52 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 3.43e-04 | 49 | 52 | 3 | IPR002172 | |
| Domain | LDLa | 3.43e-04 | 49 | 52 | 3 | SM00192 | |
| Domain | ABC_transporter-like | 3.64e-04 | 50 | 52 | 3 | IPR003439 | |
| Domain | MACPF | 4.11e-04 | 11 | 52 | 2 | PF01823 | |
| Domain | PKD_channel | 4.11e-04 | 11 | 52 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 4.11e-04 | 11 | 52 | 2 | IPR013122 | |
| Domain | MACPF | 4.93e-04 | 12 | 52 | 2 | SM00457 | |
| Domain | MACPF | 4.93e-04 | 12 | 52 | 2 | IPR020864 | |
| Domain | Laminin_G | 5.64e-04 | 58 | 52 | 3 | IPR001791 | |
| Domain | Kelch | 5.64e-04 | 58 | 52 | 3 | SM00612 | |
| Domain | 6-hairpin_glycosidase-like | 5.82e-04 | 13 | 52 | 2 | IPR008928 | |
| Domain | EGF-like_dom | 6.31e-04 | 249 | 52 | 5 | IPR000742 | |
| Domain | EGF_1 | 7.02e-04 | 255 | 52 | 5 | PS00022 | |
| Domain | Laminin_N | 8.90e-04 | 16 | 52 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 8.90e-04 | 16 | 52 | 2 | PS51117 | |
| Domain | Laminin_N | 8.90e-04 | 16 | 52 | 2 | PF00055 | |
| Domain | LamNT | 8.90e-04 | 16 | 52 | 2 | SM00136 | |
| Domain | Growth_fac_rcpt_ | 9.28e-04 | 156 | 52 | 4 | IPR009030 | |
| Domain | Kelch_1 | 9.77e-04 | 70 | 52 | 3 | PF01344 | |
| Domain | Kelch_1 | 9.77e-04 | 70 | 52 | 3 | IPR006652 | |
| Domain | ABC_membrane | 2.02e-03 | 24 | 52 | 2 | PF00664 | |
| Domain | - | 2.35e-03 | 95 | 52 | 3 | 2.60.120.200 | |
| Domain | - | 2.55e-03 | 27 | 52 | 2 | 2.130.10.80 | |
| Domain | ABC_TM1F | 2.74e-03 | 28 | 52 | 2 | PS50929 | |
| Domain | ABC1_TM_dom | 2.74e-03 | 28 | 52 | 2 | IPR011527 | |
| Domain | EGF_LAM_2 | 3.15e-03 | 30 | 52 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 3.15e-03 | 30 | 52 | 2 | PS01248 | |
| Domain | Thioredoxin | 3.36e-03 | 31 | 52 | 2 | PF00085 | |
| Domain | EGF_3 | 4.12e-03 | 235 | 52 | 4 | PS50026 | |
| Domain | Laminin_EGF | 4.27e-03 | 35 | 52 | 2 | PF00053 | |
| Domain | EGF_Lam | 4.27e-03 | 35 | 52 | 2 | SM00180 | |
| Domain | Laminin_EGF | 5.01e-03 | 38 | 52 | 2 | IPR002049 | |
| Domain | Thioredoxin_domain | 5.82e-03 | 41 | 52 | 2 | IPR013766 | |
| Domain | EGF-like_CS | 5.96e-03 | 261 | 52 | 4 | IPR013032 | |
| Pathway | BIOCARTA_MRP_PATHWAY | 9.45e-05 | 6 | 36 | 2 | M22078 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION | 1.32e-04 | 7 | 36 | 2 | M47873 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 1.76e-04 | 8 | 36 | 2 | M27006 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 1.76e-04 | 8 | 36 | 2 | MM14656 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.89e-04 | 44 | 36 | 3 | M11911 | |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 2.26e-04 | 9 | 36 | 2 | M22072 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION | 2.26e-04 | 9 | 36 | 2 | M47881 | |
| Pathway | REACTOME_MET_RECEPTOR_RECYCLING | 2.82e-04 | 10 | 36 | 2 | M27777 | |
| Pathway | REACTOME_MET_RECEPTOR_RECYCLING | 2.82e-04 | 10 | 36 | 2 | MM15516 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 3.44e-04 | 11 | 36 | 2 | M27372 | |
| Pathway | WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY | 4.12e-04 | 12 | 36 | 2 | M48316 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 4.86e-04 | 13 | 36 | 2 | M4732 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 6.52e-04 | 15 | 36 | 2 | M7146 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 8.42e-04 | 17 | 36 | 2 | MM15944 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.06e-03 | 79 | 36 | 3 | M27643 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 1.17e-03 | 20 | 36 | 2 | M917 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 1.42e-03 | 22 | 36 | 2 | M39502 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 1.49e-03 | 89 | 36 | 3 | M39398 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 2.03e-03 | 99 | 36 | 3 | MM14986 | |
| Pathway | WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY | 2.14e-03 | 27 | 36 | 2 | M39899 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 2.27e-03 | 103 | 36 | 3 | M758 | |
| Pathway | WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT | 2.47e-03 | 29 | 36 | 2 | M45551 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 2.64e-03 | 30 | 36 | 2 | MM15866 | |
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 16458078 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 10488067 | ||
| Pubmed | Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. | 2.28e-06 | 2 | 53 | 2 | 21705081 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 10552998 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 28441502 | ||
| Pubmed | Genetic dissection of the function of mammalian P-glycoproteins. | 2.28e-06 | 2 | 53 | 2 | 9196326 | |
| Pubmed | MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells. | 2.28e-06 | 2 | 53 | 2 | 18231753 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 22184139 | ||
| Pubmed | Isolation and expression of a complementary DNA that confers multidrug resistance. | 2.28e-06 | 2 | 53 | 2 | 3022150 | |
| Pubmed | ABCB1/4 gallbladder cancer risk variants identified in India also show strong effects in Chileans. | 2.28e-06 | 2 | 53 | 2 | 32058310 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 2570420 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 8898203 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 2473069 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 28274756 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 29797489 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19185004 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 3768958 | ||
| Pubmed | Hydrophobic pore gates regulate ion permeation in polycystic kidney disease 2 and 2L1 channels. | 2.28e-06 | 2 | 53 | 2 | 29899465 | |
| Pubmed | Binding of human complement C8 to C9: role of the N-terminal modules in the C8 alpha subunit. | 2.28e-06 | 2 | 53 | 2 | 12463754 | |
| Pubmed | Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice. | 2.28e-06 | 2 | 53 | 2 | 38522903 | |
| Pubmed | Localization of the human multiple drug resistance gene, MDR1, to 7q21.1. | 2.28e-06 | 2 | 53 | 2 | 3477522 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 18215618 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 16857572 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 20209493 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 20408813 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 1969609 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 24140176 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 4063341 | ||
| Pubmed | Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. | 2.28e-06 | 2 | 53 | 2 | 9419367 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 2248681 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 17440929 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 7832992 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 11826402 | ||
| Pubmed | What have we learnt thus far from mice with disrupted P-glycoprotein genes? | 2.28e-06 | 2 | 53 | 2 | 8763339 | |
| Pubmed | Biliary secretion of alpha-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice. | 2.28e-06 | 2 | 53 | 2 | 9473291 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 10453001 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 2471060 | ||
| Pubmed | 4.68e-06 | 441 | 53 | 7 | 12853948 | ||
| Pubmed | Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. | 6.83e-06 | 3 | 53 | 2 | 7814632 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 25029804 | ||
| Pubmed | LanCL proteins are not Involved in Lanthionine Synthesis in Mammals. | 6.83e-06 | 3 | 53 | 2 | 28106097 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 9778357 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 21507937 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 24732756 | ||
| Pubmed | Polycystin-2 interacts with troponin I, an angiogenesis inhibitor. | 6.83e-06 | 3 | 53 | 2 | 12525172 | |
| Pubmed | LanCLs add glutathione to dehydroamino acids generated at phosphorylated sites in the proteome. | 6.83e-06 | 3 | 53 | 2 | 33932340 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 8547326 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 9542318 | ||
| Pubmed | Polycystin-2 expression and function in adult mouse lacrimal acinar cells. | 6.83e-06 | 3 | 53 | 2 | 21508103 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 19590752 | ||
| Pubmed | Structural and functional characterization of the mouse multidrug resistance gene family. | 6.83e-06 | 3 | 53 | 2 | 1980424 | |
| Pubmed | Specific association of the gene product of PKD2 with the TRPC1 channel. | 1.36e-05 | 4 | 53 | 2 | 10097141 | |
| Pubmed | Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement. | 1.36e-05 | 4 | 53 | 2 | 3624872 | |
| Pubmed | Functional cross-talk between Rab14 and Rab4 through a dual effector, RUFY1/Rabip4. | 1.36e-05 | 4 | 53 | 2 | 20534812 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 2069718 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 16618117 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 11698076 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 10551839 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 15159385 | ||
| Pubmed | Troponin I binds polycystin-L and inhibits its calcium-induced channel activation. | 2.27e-05 | 5 | 53 | 2 | 12809519 | |
| Pubmed | Genetic mapping of the mouse gene encoding dipeptidyl aminopeptidase-like proteins. | 2.27e-05 | 5 | 53 | 2 | 8499659 | |
| Pubmed | The Rab protein family: genetic mapping of six Rab genes in the mouse. | 3.40e-05 | 6 | 53 | 2 | 8825628 | |
| Pubmed | Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9. | 3.40e-05 | 6 | 53 | 2 | 22832194 | |
| Pubmed | High-resolution genetic map and YAC contig around the mouse neurological locus reeler. | 3.40e-05 | 6 | 53 | 2 | 7894155 | |
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 20301304 | ||
| Pubmed | CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers. | 4.76e-05 | 7 | 53 | 2 | 30552328 | |
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 12482924 | ||
| Pubmed | 1.02e-04 | 10 | 53 | 2 | 16805797 | ||
| Pubmed | 1.02e-04 | 10 | 53 | 2 | 12068294 | ||
| Pubmed | 1.02e-04 | 10 | 53 | 2 | 10198174 | ||
| Pubmed | 1.02e-04 | 10 | 53 | 2 | 10329441 | ||
| Pubmed | 1.24e-04 | 11 | 53 | 2 | 10811835 | ||
| Pubmed | Current insights into the formation and breakdown of hemidesmosomes. | 1.24e-04 | 11 | 53 | 2 | 16757171 | |
| Pubmed | 1.28e-04 | 1285 | 53 | 9 | 35914814 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 2.03e-04 | 1070 | 53 | 8 | 23533145 | |
| Pubmed | 2.70e-04 | 16 | 53 | 2 | 19794400 | ||
| Pubmed | 4.25e-04 | 20 | 53 | 2 | 21072184 | ||
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | 4.37e-04 | 418 | 53 | 5 | 32552912 | |
| Pubmed | 5.61e-04 | 105 | 53 | 3 | 23284306 | ||
| Pubmed | 7.80e-04 | 27 | 53 | 2 | 16460286 | ||
| Pubmed | 8.49e-04 | 733 | 53 | 6 | 34672954 | ||
| Pubmed | 1.10e-03 | 32 | 53 | 2 | 18842294 | ||
| Pubmed | 1.17e-03 | 33 | 53 | 2 | 19834762 | ||
| Pubmed | Proteotyping of knockout mouse strains reveals sex- and strain-specific signatures in blood plasma. | 1.24e-03 | 34 | 53 | 2 | 34050187 | |
| Pubmed | 1.33e-03 | 536 | 53 | 5 | 12690205 | ||
| Pubmed | 1.47e-03 | 37 | 53 | 2 | 39305123 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q21 | 1.16e-03 | 178 | 53 | 3 | chr7q21 | |
| GeneFamily | ATP binding cassette subfamily B | 2.22e-04 | 11 | 37 | 2 | 806 | |
| GeneFamily | Transient receptor potential cation channels | 1.49e-03 | 28 | 37 | 2 | 249 | |
| GeneFamily | Complement system|Sushi domain containing | 2.46e-03 | 36 | 37 | 2 | 492 | |
| GeneFamily | Kelch like|BTB domain containing | 3.33e-03 | 42 | 37 | 2 | 617 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 7.82e-03 | 65 | 37 | 2 | 388 | |
| GeneFamily | Solute carriers | 8.39e-03 | 395 | 37 | 4 | 752 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.12e-05 | 250 | 53 | 6 | M11318 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP | 5.12e-05 | 199 | 53 | 5 | M3478 | |
| Coexpression | GSE4142_PLASMA_CELL_VS_GC_BCELL_UP | 5.24e-05 | 200 | 53 | 5 | M6390 | |
| Coexpression | GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN | 5.24e-05 | 200 | 53 | 5 | M9735 | |
| Coexpression | GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP | 5.24e-05 | 200 | 53 | 5 | M7831 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-07 | 110 | 53 | 5 | c80d1c3df75648e2c8f6832279c2acca63d76681 | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 157 | 53 | 5 | 2ac4695d9e4ca8d4ba19c555e9a1d86ac8f398ab | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 157 | 53 | 5 | 8a393eece90fb9a1b7c356736bdb36277261fbd3 | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 157 | 53 | 5 | 8d30d8e6fae93afcada6bd68799439335cd65b69 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.13e-06 | 176 | 53 | 5 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.35e-06 | 193 | 53 | 5 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.43e-06 | 194 | 53 | 5 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.40e-06 | 108 | 53 | 4 | d620f07243c2628494e689bbfabc14c453f4b1f4 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.69e-05 | 129 | 53 | 4 | cbeeaa554da971ba2e4c4b82c85a1d070a45abb8 | |
| ToppCell | Striatum-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.91e-05 | 50 | 53 | 3 | 5c06f52adbb2bbcf156f82e930948b10331ed730 | |
| ToppCell | Striatum-Macroglia-OLIGODENDROCYTE-O1-Trf|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.91e-05 | 50 | 53 | 3 | 1f1fee2a62d0665ac6ef8ece456c51e3cec3a6b6 | |
| ToppCell | Striatum-Macroglia-OLIGODENDROCYTE-O1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.91e-05 | 50 | 53 | 3 | 041339abc4feded9a58b797204e04052e338c009 | |
| ToppCell | Striatum-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.91e-05 | 50 | 53 | 3 | 301eaec701ee1f7ce825dfb905c37c7107e3dc88 | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.55e-05 | 166 | 53 | 4 | 94a00edf66d54bc5f7343daea700ca26cf38fd90 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 178 | 53 | 4 | 6bef4ef48f649c6e38ae732bc08e6d7814db588b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.23e-05 | 180 | 53 | 4 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.23e-05 | 180 | 53 | 4 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.23e-05 | 180 | 53 | 4 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 181 | 53 | 4 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 183 | 53 | 4 | 2df1611c8acccb2a6f233d3d68bd9df2381a7278 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 184 | 53 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 184 | 53 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 184 | 53 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 184 | 53 | 4 | 6388c47b7f1d8203e3069eba0e74107256dcae51 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.78e-05 | 184 | 53 | 4 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 184 | 53 | 4 | d83ae1dc64aa1b27d3b524c137567418cc0ff8c6 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 186 | 53 | 4 | 02fbb02c495e7d64c4ab50e42e5197782f2c0816 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.07e-05 | 186 | 53 | 4 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.22e-05 | 187 | 53 | 4 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.22e-05 | 187 | 53 | 4 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-05 | 189 | 53 | 4 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 190 | 53 | 4 | e243b5fbb17b9ec3cc90bbe970c1d30b0fd1c2e1 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 190 | 53 | 4 | fe844559b95832845d2e8d3ab4b57e3d558bc372 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.83e-05 | 191 | 53 | 4 | e314dd8f1a841cab847ae3703bedfe1bc623ac61 | |
| ToppCell | ASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.83e-05 | 191 | 53 | 4 | 0c4b926a28bc94f3cf4d68a911c0a189f6ff505e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.83e-05 | 191 | 53 | 4 | 8a5a2188b13ef4bbfd626a42565566708a751c1b | |
| ToppCell | LAM-Epithelial-AirwayEpi|LAM / Condition, Lineage and Cell class | 7.99e-05 | 192 | 53 | 4 | 7404fc65be3b7bd09447725b43fa31819004dfee | |
| ToppCell | Immune_cells-small_pre-B.|Immune_cells / Lineage and Cell class | 8.32e-05 | 194 | 53 | 4 | 6a440c09805110b1e48e5959a3a9e094c6716bfb | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-05 | 194 | 53 | 4 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 8.32e-05 | 194 | 53 | 4 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 8.49e-05 | 195 | 53 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 8.65e-05 | 196 | 53 | 4 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 8.83e-05 | 197 | 53 | 4 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 197 | 53 | 4 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | distal-Epithelial-Ciliated-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.00e-05 | 198 | 53 | 4 | d30d6c6a0a78b7571318b5b2a0186df96dd0f5a9 | |
| ToppCell | medial-Epithelial-Ciliated-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.18e-05 | 199 | 53 | 4 | 526002f16bbf61cf086278d45a401cc0b0b757a8 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.18e-05 | 199 | 53 | 4 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | distal-Epithelial-Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.18e-05 | 199 | 53 | 4 | 6ce0df4a6f4d9353919e26ffab97c9ec89911da6 | |
| ToppCell | medial-Epithelial-Ciliated|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.18e-05 | 199 | 53 | 4 | a2daa42b100c422dc8c04fb7d2ebf54293eef574 | |
| ToppCell | distal-Epithelial-Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.18e-05 | 199 | 53 | 4 | 18ca031cfe702afb9bf94e03c0f3680c38e7599e | |
| ToppCell | distal-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.18e-05 | 199 | 53 | 4 | 97b66b82c76c7bc1fcd7da7b94dd2aa2d4d70a60 | |
| ToppCell | distal-1-Epithelial-Ciliated|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.18e-05 | 199 | 53 | 4 | 4120e4a2bc05adebe1e1e9670ed7ea55142eb83d | |
| ToppCell | medial-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.18e-05 | 199 | 53 | 4 | c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.36e-05 | 200 | 53 | 4 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.36e-05 | 200 | 53 | 4 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | severe_influenza-B_cell|World / disease group, cell group and cell class (v2) | 1.47e-04 | 86 | 53 | 3 | 7b595bcba4bcb72b7de7c06e19f690f0c739c529 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-epithelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 93 | 53 | 3 | 0d6d1d8dd9c91ba31eb35a4b5979d087890936c1 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 93 | 53 | 3 | abffb1fd5a919b7c08e62e1c3c08a8dd8783a4ca | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 93 | 53 | 3 | dbfaa7f23d25f5c286ab7ca3ca795b734cb95153 | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O2-Tfr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.10e-04 | 97 | 53 | 3 | 4b74b3c5b9590a8215b7370b37e9723e9f040b9c | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.10e-04 | 97 | 53 | 3 | 7b17dc28454949a23701ab127300a29a8899d7d6 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.44e-04 | 102 | 53 | 3 | 2c3622fc3cd62d9b7e185d0204cf7f03e7dde73c | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Testicular_Germ_Cell_Tumor-2|TCGA-Testes / Sample_Type by Project: Shred V9 | 3.13e-04 | 111 | 53 | 3 | dbd6a30298c9f3b09b2b5ad93a14305e3438793d | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.54e-04 | 126 | 53 | 3 | e33957cf1541733b06de9f9e7b2801b3d8ae831d | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.64e-04 | 127 | 53 | 3 | 5e4d110cc6e68cd8fc7a4771a65e6f8cd83e7721 | |
| ToppCell | severe_influenza-B_cell|severe_influenza / disease group, cell group and cell class (v2) | 4.75e-04 | 128 | 53 | 3 | 92b250186d6bb08ce4f2f5cc4fb93928f6b92d3a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.97e-04 | 130 | 53 | 3 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | facs-Heart-RV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-04 | 135 | 53 | 3 | 1fe684ed5913ae757ad6befbbe12d1bee481dd12 | |
| ToppCell | facs-Heart-RV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-04 | 135 | 53 | 3 | 99e7ac9b1139fe4ff036f6f048a8f1cc514c1fb9 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-professional_antigen_presenting_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 139 | 53 | 3 | 292533e04178dd36d57377562077f9deb2cb9746 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 139 | 53 | 3 | 22a769d5195ed761ef333ef542746e1ba617a698 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-04 | 141 | 53 | 3 | 091b5b72811db5fca2314f4a79d467566920e257 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.69e-04 | 144 | 53 | 3 | 5e948d4cb913ccd8f82262a1b4d20967aadab3ab | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-04 | 145 | 53 | 3 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.83e-04 | 145 | 53 | 3 | 8b13b576fd2e6e33ccb146860a91a53cee0cdd4d | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar-Club_cell|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.39e-04 | 149 | 53 | 3 | 82edfecb7981d8c336cf9da7aa7e2b3f7a017a3f | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.39e-04 | 149 | 53 | 3 | 14a01ae540db8a350ea26a350b2e6ce6c07639d9 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-4|TCGA-Bladder / Sample_Type by Project: Shred V9 | 7.53e-04 | 150 | 53 | 3 | bcb99c6fa81052556ab30f9db5875fccf1ae724b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.13e-04 | 154 | 53 | 3 | e94cd11488003347120eacd3ced0a8923ed09ccc | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.13e-04 | 154 | 53 | 3 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.13e-04 | 154 | 53 | 3 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-04 | 156 | 53 | 3 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.43e-04 | 156 | 53 | 3 | bb2876bdf2375866d7509eba3c48322326349fa8 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-04 | 157 | 53 | 3 | ed9c9feefc06c9536c03bedbc3397a2ee492a78e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-04 | 157 | 53 | 3 | 9665a1375cfd8e9b8781c852686591226c0e0d9a | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-04 | 157 | 53 | 3 | fddcb24776b9f86e000208bae54541b15b2adefd | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-04 | 158 | 53 | 3 | 12a82230c01de552f12977634c304626e1cd6903 | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-04 | 158 | 53 | 3 | bd432ecd2524656804e7c2775250e27db7906b70 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-9|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 8.91e-04 | 159 | 53 | 3 | f376bf6cd0ed374211edac3c384f3a78f0caef2a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.07e-04 | 160 | 53 | 3 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.07e-04 | 160 | 53 | 3 | 04714d0b9bad4c11fa193ed168e2d84a4df39e2e | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-04 | 160 | 53 | 3 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.24e-04 | 161 | 53 | 3 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | Mild-MAIT|Mild / Disease group and Cell class | 9.24e-04 | 161 | 53 | 3 | 0c1a04485708d5302600cdc2d7dac1cb76b4033a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.24e-04 | 161 | 53 | 3 | f5df8c6a340d5026726804b103e32137f363ca40 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.41e-04 | 162 | 53 | 3 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 9.41e-04 | 162 | 53 | 3 | b115b5799137122bd60696f8ae2aebadad6cd044 | |
| Drug | avermectin | 4.72e-06 | 48 | 53 | 4 | CID006450460 | |
| Drug | 1,9-dideoxyforskolin | 5.32e-06 | 2 | 53 | 2 | ctd:C047983 | |
| Drug | magnesium | MGAM CERK POLR3B RAB4B PDK4 ENTPD6 LAMA3 GRIA1 PLEC NNT RAB4A ABCB1 ABCB4 | 7.83e-06 | 1325 | 53 | 13 | CID000000888 |
| Drug | Pgh1 | 7.91e-06 | 17 | 53 | 3 | CID005283048 | |
| Drug | C19565 | 1.32e-05 | 20 | 53 | 3 | CID000107819 | |
| Drug | AC1L3NFS | 1.54e-05 | 21 | 53 | 3 | CID000092111 | |
| Drug | DA-8159 | 1.54e-05 | 21 | 53 | 3 | CID006918523 | |
| Drug | Technetium Tc 99m Sestamibi | 1.59e-05 | 3 | 53 | 2 | ctd:D017256 | |
| Drug | N(3)ATP | 1.59e-05 | 3 | 53 | 2 | CID000133414 | |
| Drug | pregnenolone-16 alpha-carbonitrile | 1.80e-05 | 67 | 53 | 4 | CID000015032 | |
| Drug | dimethylaminobenzoate | 3.18e-05 | 4 | 53 | 2 | CID012241998 | |
| Drug | 3 alpha,6 alpha-dihydroxy-5 beta-cholanoic acid | 4.17e-05 | 29 | 53 | 3 | CID000006747 | |
| Drug | rostafuroxin | 5.29e-05 | 5 | 53 | 2 | ctd:C106263 | |
| Drug | AC1L2MCS | 5.29e-05 | 5 | 53 | 2 | CID000023441 | |
| Drug | pyropheophorbide-a methyl ester | 7.93e-05 | 6 | 53 | 2 | CID005476777 | |
| Drug | PIHCA | 7.93e-05 | 6 | 53 | 2 | CID000108097 | |
| Drug | v 104 | 7.93e-05 | 6 | 53 | 2 | CID000107262 | |
| Drug | AC1L99H3 | 7.93e-05 | 6 | 53 | 2 | CID000440540 | |
| Drug | AC1L3Z73 | 7.93e-05 | 6 | 53 | 2 | CID000097765 | |
| Drug | LY294002; Up 200; 10uM; SKMEL5; HG-U133A | 8.57e-05 | 193 | 53 | 5 | 501_UP | |
| Drug | MIANS | 8.75e-05 | 37 | 53 | 3 | CID000119532 | |
| Drug | galangin | 8.75e-05 | 37 | 53 | 3 | CID005281616 | |
| Drug | Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 6208_DN | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Up 200; 9.8uM; HL60; HG-U133A | 9.90e-05 | 199 | 53 | 5 | 2012_UP | |
| Drug | valinomycin | 1.03e-04 | 39 | 53 | 3 | CID000005649 | |
| Drug | C12-NBD-PC | 1.11e-04 | 7 | 53 | 2 | CID006439314 | |
| Drug | N-dodecylimidazole | 1.11e-04 | 7 | 53 | 2 | CID000078002 | |
| Drug | racemethorphan | 1.13e-04 | 107 | 53 | 4 | CID000003008 | |
| Drug | perfluoro-n-nonanoic acid | 1.44e-04 | 114 | 53 | 4 | ctd:C101816 | |
| Drug | tBCEU | 1.48e-04 | 8 | 53 | 2 | CID000164059 | |
| Drug | tri-n-butylmethylammonium | 1.48e-04 | 8 | 53 | 2 | CID000036208 | |
| Drug | nicotine glucuronide | 1.48e-04 | 8 | 53 | 2 | CID003035848 | |
| Drug | iodoarylazidoprazosin | 1.48e-04 | 8 | 53 | 2 | CID000115344 | |
| Drug | T beta-MC | 1.48e-04 | 8 | 53 | 2 | CID000168408 | |
| Drug | thiopyrylium | 1.48e-04 | 8 | 53 | 2 | CID011344401 | |
| Drug | tXMP | 1.48e-04 | 8 | 53 | 2 | CID003081384 | |
| Drug | ciprofibrate | 1.49e-04 | 115 | 53 | 4 | ctd:C019304 | |
| Drug | AC1L1R04 | 1.80e-04 | 47 | 53 | 3 | CID000008439 | |
| Drug | GW3965 | 1.80e-04 | 47 | 53 | 3 | CID000447905 | |
| Drug | AC1L8B0O | 1.89e-04 | 9 | 53 | 2 | CID000324941 | |
| Drug | Ca 5 | 1.89e-04 | 9 | 53 | 2 | CID000090511 | |
| Drug | So324 | 1.89e-04 | 9 | 53 | 2 | CID000462261 | |
| Drug | c219 | 1.89e-04 | 9 | 53 | 2 | CID004198643 | |
| Drug | atorvastatin lactone | 1.89e-04 | 9 | 53 | 2 | CID006483036 | |
| Disease | polycystic kidney disease 2 (implicated_via_orthology) | 9.13e-06 | 3 | 52 | 2 | DOID:0110859 (implicated_via_orthology) | |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 3.25e-05 | 35 | 52 | 3 | DOID:0050861 (is_implicated_in) | |
| Disease | gallbladder neoplasm | 1.09e-04 | 9 | 52 | 2 | EFO_0004606 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.09e-04 | 9 | 52 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Alzheimer disease, dementia | 1.99e-04 | 12 | 52 | 2 | MONDO_0001627, MONDO_0004975 | |
| Disease | Liver carcinoma | 2.60e-04 | 507 | 52 | 6 | C2239176 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 2.73e-04 | 14 | 52 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 3.15e-04 | 15 | 52 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | Intrahepatic cholestasis of pregnancy | 3.60e-04 | 16 | 52 | 2 | EFO_0009048 | |
| Disease | Nonsyndromic Deafness | 4.00e-04 | 81 | 52 | 3 | C3711374 | |
| Disease | Antibody Deficiency Syndrome | 4.07e-04 | 17 | 52 | 2 | C0003257 | |
| Disease | epilepsy (biomarker_via_orthology) | 6.26e-04 | 21 | 52 | 2 | DOID:1826 (biomarker_via_orthology) | |
| Disease | Immunologic Deficiency Syndromes | 7.53e-04 | 23 | 52 | 2 | C0021051 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 8.38e-04 | 239 | 52 | 4 | EFO_0010934 | |
| Disease | apolipoprotein B measurement | 1.06e-03 | 663 | 52 | 6 | EFO_0004615 | |
| Disease | forced expiratory volume, response to bronchodilator | 1.11e-03 | 445 | 52 | 5 | EFO_0004314, GO_0097366 | |
| Disease | Toxic Encephalitis | 1.20e-03 | 29 | 52 | 2 | C0154659 | |
| Disease | Neurotoxicity Syndromes | 1.20e-03 | 29 | 52 | 2 | C0235032 | |
| Disease | Encephalopathy, Toxic | 1.20e-03 | 29 | 52 | 2 | C0149504 | |
| Disease | Complement deficiency disease | 1.55e-03 | 33 | 52 | 2 | C0272242 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYLSYVRYGFEGVIL | 566 | Q9H172 | |
| YITSGSMGGIYEYIL | 341 | P07357 | |
| LLGDVAYYDYQGSLE | 256 | Q9UEY8 | |
| AYYLEAYGLAQGAVA | 1806 | Q8IYW2 | |
| LYKEYDLYGQGIFTG | 571 | A6NK59 | |
| LSDYIGEYSYLGTTL | 516 | Q86XH1 | |
| SYYRGAAGALLVYDI | 81 | P20338 | |
| SYYRGAAGALLVYDI | 76 | P61018 | |
| YYYSGIGAGVLVAAY | 116 | P08183 | |
| YSLSGYGTDAIIYLK | 351 | Q16654 | |
| LDGTGYGDYVKIYDG | 306 | Q9Y561 | |
| GDKVSSYGGYLTYQA | 1526 | Q16787 | |
| EDYEVLYTIGTGSYG | 6 | P51955 | |
| GQSIDTYGKGLYYLA | 2651 | O43451 | |
| SGVGAGIDSYYEYLL | 286 | Q9BZQ6 | |
| AGYLYALLYLNTEIG | 201 | Q9NS86 | |
| GTLYRYTLLLYGTAE | 566 | Q6UW60 | |
| NGSLYVFGGTTGYIY | 216 | Q6PID8 | |
| DYLSFGYVYVGLRGT | 296 | Q9Y2G8 | |
| GGSGRDYSKYYSIIE | 186 | Q2M2I5 | |
| YYGTEYLGAAHGLSS | 226 | Q6ZV70 | |
| YAYYYSGLGAGVLVA | 116 | P21439 | |
| YLKGYVYIIGGFDSV | 336 | Q6JEL2 | |
| GELYALGGYDGQSYL | 386 | Q9NXS3 | |
| NYLYVVGGHSGSSYL | 526 | Q9NXS3 | |
| LRYSVSLLGYGFYGD | 281 | Q8TCT0 | |
| LAGSEYLKLGYVSRY | 441 | O15371 | |
| ADIGSNGYIRYSLYG | 3056 | Q8TDW7 | |
| LGTYLTGGEGAYLYS | 536 | Q5TEA3 | |
| YLGEETYGGTRLFTY | 66 | Q7Z692 | |
| LILGVLGVLAYGIYY | 261 | Q53GD3 | |
| VAVFGKDYGGYLSTY | 706 | P42658 | |
| GYSYRLEIVSDGKYG | 451 | P42261 | |
| LVSYIGLKGLYFTGY | 391 | Q9UMX9 | |
| LGSAYKLQSYTEGYG | 101 | Q8NBW4 | |
| YSSSGSLGGLYELIY | 346 | P02748 | |
| LGAGLLLGAYVLVYY | 6 | Q6UX07 | |
| GEGSYYLTTTYGALE | 821 | Q8TB24 | |
| ETFDGLYYYLSGKGS | 161 | Q6ZRI0 | |
| LYYYLSGKGSYTLVG | 166 | Q6ZRI0 | |
| VGGYLAALYSGYNIE | 606 | Q13423 | |
| YPNGVITSYGLYLDG | 2266 | O75445 | |
| AFSYYYDLAAGVGLI | 381 | O75354 | |
| EYGDVGIYVYLAGCS | 666 | P58743 | |
| GTYLYAETGSKYVGT | 126 | Q8WYR4 | |
| VLGTDGGRYDVYLYD | 311 | Q9Y6Y8 | |
| GLYTLGTVVVDYRGY | 466 | O75153 | |
| EAGNYLKGYVITGIY | 546 | Q9P2K2 | |
| YNYLGKDYVTSGITG | 981 | Q9NW08 | |
| CYLYGTGSVAGVYLP | 3821 | Q15149 | |
| GIIATYSGAGYYLDL | 381 | Q13563 | |
| RLTSYSGGGYYLDLP | 261 | Q9P0L9 | |
| GQRGLVLYYSLAAGY | 1231 | Q96AY4 | |
| EYGLYSIYQGGIFEL | 236 | P50591 | |
| LYGALLLAEGFYTTG | 81 | P60201 |